A HPLC method has been developed for the determination of coating integrity of topiramate sprinkle formulation. This method determines the completeness of the sprinkle coating and, indirectly, the completeness of taste masking of the product. This method utilizes a sample preparation where the sprinkles are placed in a specially designed stainless steel basket equipped with a screen, 25-mesh size, at the bottom. Water is used to solubilize any incompletely coated drug. The aqueous solution is analyzed for topiramate using a phenyl column in the reversed-phase mode, isocratic elution, and refractive index detection. This analytical method, for recovered topiramate, provides an indirect measure of drug taste-masking in the sprinkle formulation. It was also used in formulation selection by screening sprinkles beads that contained different amounts of coating to see which formula can best mask the taste with an acceptable level of exposed topiramate drug substance. This method has been validated to meet FDA validation guidelines.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0731-7085(02)00004-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Potentiometric Electronic Tongue for the Evaluation of Multiple-Unit Pellet Sprinkle Formulations of Rosuvastatin Calcium.
Materials (Basel)
October 2024
Department of Analytical Chemistry, Institute of Chemical Sciences, Faculty of Chemistry, Maria Curie-Skłodowska University, M. Curie-Skłodowska Sq. 3, 20-031 Lublin, Poland.
Sprinkle formulations represent an interesting genre of medicinal products. A frequent problem, however, is the need to mask the unpleasant taste of these drug substances. In the present work, we propose the use of a novel sensor array based on solid-state ion-selective electrodes to evaluate the taste-masking efficiency of rosuvastatin (ROS) sprinkle formulations.
View Article and Find Full Text PDFManagement Challenges and Potential Malabsorption of Valproic Acid in a Patient with Bipolar Disorder and Gastrointestinal History.
Case Rep Psychiatry
July 2024
Virginia Tech Carilion School of Medicine, Roanoke, VA, USA.
Bipolar disorder is a chronic psychiatric condition typically managed using mood stabilizers such as valproic acid, lithium, and atypical antipsychotics, the former which is absorbed in the gastrointestinal tract. This case report presents the challenges encountered in managing bipolar disorder in a patient with a history of extensive gastrointestinal (GI) issues. The patient was initially treated with lithium but experienced adverse effects, prompting a switch to valproic acid (VPA) tablets.
View Article and Find Full Text PDFAlkindi Sprinkle for Pediatric Patients With Primary Adrenocortical Insufficiency: A Narrative Review.
Cureus
March 2024
Pain Medicine, Paolo Procacci Foundation, Rome, ITA.
Adrenocortical insufficiency, also known as adrenal insufficiency (AI), is an endocrine disorder characterized by inadequate production of adrenal hormones, including glucocorticoids and mineralocorticoids (MCs). The condition can be categorized as primary, secondary, or tertiary AI, depending on the location of the defect. Classical symptoms of AI include weakness, fatigue, abdominal pain, tachycardia, hypotension, electrolyte imbalances, and hyperpigmentation.
View Article and Find Full Text PDFWurster Technology-Assisted Step-by-Step Engineering of Multi-layered Pellets (Sprinkles): Microscopy, Micro-CT, and e-Tongue-Based Analysis.
AAPS PharmSciTech
February 2024
Formulation Research and Development, Global Drug Development/Technical Research and Development, Novartis Healthcare Pvt. Ltd., Genome Valley, Hyderabad, 500101, India.
Article Synopsis
- Advances in formulation and characterization techniques, including micro-computed tomography (micro-CT) and e-tongue analysis, have enhanced the development of multi-layered-coated pellets for better drug delivery and palatability.
- The study found that these pellets displayed a uniform spherical shape and coating, confirmed through various microscopy methods, ensuring consistent quality.
- Results indicated that the multi-layered design effectively controls drug release while the e-tongue technique offers a fast way to assess taste masking, making this formulation ideal for pediatric and geriatric applications.
A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder.
Expert Rev Neurother
April 2024
Division of Developmental-Behavioral Pediatrics, Nationwide Children's Hospital, Columbus, OH, USA.
Introduction: Amphetamine preparations are one of the two categories of stimulant medications approved for the treatment of attention deficit hyperactivity disorder (ADHD). Optimal treatment of ADHD aims to reduce core symptoms for as much of the waking hours as possible, leading to longer-acting delivery formats. In addition, the pediatric population commonly has difficulty swallowing pills and manufacturers have developed a variety of options to facilitate this concern.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!